Figure S4 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Authors :: Alexandra S. Zimmer
Patricia S. Steeg
Stanley Lipkowitz
Imran Khan
Karen L. Smith
Carol Tweed
Roisín M. Connolly
Carey K. Anders
Mark R. Gilbert
Scott Carter
Priscilla Brastianos
Elizabeth Vera
Tito R. Mendoza
William D. Figg
Oluwatobi Arisa
Brett Mozarsky
Cody J. Peer
Ritu Shah
Dee Dee Smart
Eric Burton
Terri S. Armstrong
Xiaolin Wu
Nicole Houston
Darryl Nousome
Seth M. Steinberg
Wei Zhang
Sarah Jenkins
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Fig. 4. Histogram illustrating ERBB2 relative copy number in plasma and CSF cfDNA samples from 12 patients during their T samples from 12 patients during their Tsamples from 12 patients during their T samples from 12 patients during their T-DM1/TMZ combination therapy.

Tools